References:
1. Lunde LE, Dasaraju S, Cao Q, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant . Nov 2015;50(11):1432-7. doi:10.1038/bmt.2015.162
2. Decker DB, Karam JA, Wilcox DT. Pediatric hemorrhagic cystitis.J Pediatr Urol . Aug 2009;5(4):254-64. doi:10.1016/j.jpurol.2009.02.199
3. West NJ. Prevention and treatment of hemorrhagic cystitis.Pharmacotherapy . 1997 Jul-Aug 1997;17(4):696-706.
4. Shi CW, Asch SM, Fielder E, et al. Usage patterns of over-the-counter phenazopyridine (pyridium). J Gen Intern Med . Apr 2003;18(4):281-7. doi:10.1046/j.1525-1497.2003.20709.x
5. Noonan HM, Kimbrell M, Johnson WB, Reuler JB. Phenazopyridine-induced hemolytic anemia. Urology . Jun 1983;21(6):623-4. doi:10.1016/0090-4295(83)90207-8
6. Gaines KK. Phenazopyridine hydrochloride: the use and abuse of an old standby for UTI. Urol Nurs . Jun 2004;24(3):207-9.
7. Eisinger AJ, Jones R. Phenazopyridine-hydrochloride haemolysis.Lancet . Jan 1969;1(7586):151. doi:10.1016/s0140-6736(69)91157-x
8. Crawford SE, Moon AE, Panos TC, Hooks CA. Methemoglobinemia associated with pyridium administration; report of a case. J Am Med Assoc . May 1951;146(1):24-5. doi:10.1001/jama.1951.03670010028007
9. Shore SN, Britnell SR, Brown JN. Safety analysis of long-term phenazopyridine use for radiation cystitis. J Oncol Pharm Pract . Mar 2020;26(2):306-311. doi:10.1177/1078155219842646